Toggle navigation
Home
Search
Services
Blog
Contact
About
Immunoglobulin T-Cell Stimulators for Cancer Therapy
Fry, Kirk
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 11 grants from Kirk Fry
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Event-Related Potentials in Schizophrenia During Visual Search
Glucocorticoid Fast Feedback Regulation in Depression
Actg 220 - Pre-Enrollment Protocol for HIV Infected Adolescents
Vanguard Center for Women's Health Initiative
RUI: Sortase-Mediated Ligations for Probing Binding Mechanisms of Large Disordered Proteins
Recently added grants:
Investigating the role of the mitochondrial pyruvate carrier in colon tumorigenesis
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
Defining the contributions of WT RAS in RAS-mutant lung cancer
CXCL12/CXCR4 regulation of PI4KIIIalpha activity in metastatic prostate tumors
Identification of functional non-coding RNAs in Human Breast Cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057773-000
Application #
3613362
Study Section
Project Start
1985-09-20
Project End
Budget Start
1985-09-20
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Comments
Be the first to comment on this grant